NAT2 and lung carcinoma: Several studies have attempted to explain the association between NAT2 polymorphism and numerous cancer types including breast, lung cancer, acute lymphoblastic leukemia and acute myeloid leukemia (Liu et al., 2015; Zou et al., 2017; Hara et al., 2017).